Arxis, Inc. (NASDAQ:ARXS) Receives $53.73 Average PT from Brokerages

Arxis, Inc. (NASDAQ:ARXS) has received an average rating of “Moderate Buy” from the thirteen brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $53.7273.

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $60.00 price target on shares of Arxis in a report on Sunday, August 2nd. Morgan Stanley restated an “overweight” rating and set a $62.00 price objective on shares of Arxis in a report on Monday, August 3rd. Wells Fargo & Company upped their price objective on Arxis from $52.00 to $63.00 and gave the company an “overweight” rating in a research report on Tuesday, August 4th. Royal Bank Of Canada increased their target price on Arxis from $46.00 to $50.00 and gave the stock a “sector perform” rating in a research note on Friday, July 31st. Finally, Citigroup lifted their target price on Arxis from $61.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th.

Arxis Stock Up 0.4%

ARXS stock opened at $49.70 on Friday. Arxis has a twelve month low of $33.15 and a twelve month high of $61.50. The company has a market capitalization of $20.75 billion and a PE ratio of 621.25. The company has a debt-to-equity ratio of 0.38, a current ratio of 5.21 and a quick ratio of 3.79. The company’s fifty day moving average price is $50.82.

Arxis (NASDAQ:ARXS) last released its earnings results on Wednesday, July 29th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.35. The firm had revenue of $500.73 million during the quarter. Arxis’s revenue for the quarter was up 25.0% on a year-over-year basis. As a group, equities research analysts expect that Arxis will post 0.57 EPS for the current year.

Institutional Investors Weigh In On Arxis

Several large investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company purchased a new stake in shares of Arxis in the second quarter valued at approximately $207,000. Amundi bought a new position in shares of Arxis during the 2nd quarter worth $358,000. IMC Chicago LLC bought a new position in shares of Arxis during the 2nd quarter worth $1,146,000. Grandeur Peak Global Advisors LLC bought a new stake in shares of Arxis in the second quarter valued at about $2,740,000. Finally, BlueCrest Capital Management Ltd purchased a new stake in Arxis in the second quarter worth about $7,389,000.

Arxis Company Profile

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.